Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo–purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
Christian H. Geisler(Copenhagen University Hospital)
Cited by 622
Related Papers
ESMO Guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)
|Annals of Oncology|2012|218
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 cases
|Blood|2011|178
Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network
|Journal of Clinical Oncology|2014|164
Treatment of Older Patients With Mantle Cell Lymphoma (MCL): Long-Term Follow-Up of the Randomized European MCL Elderly Trial
|Journal of Clinical Oncology|2019|143